{{Rsnum
|rsid=3752462
|Gene=MYH9
|Chromosome=22
|position=36314138
|Orientation=plus
|GMAF=0.4532
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYH9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 39.8 | 13.3
| HCB | 4.4 | 40.9 | 54.7
| JPT | 7.1 | 37.2 | 55.8
| YRI | 4.8 | 35.4 | 59.9
| ASW | 8.8 | 49.1 | 42.1
| CHB | 4.4 | 40.9 | 54.7
| CHD | 6.4 | 27.5 | 66.1
| GIH | 17.8 | 41.6 | 40.6
| LWK | 1.8 | 41.8 | 56.4
| MEX | 43.1 | 39.7 | 17.2
| MKK | 7.7 | 47.4 | 44.9
| TSI | 35.3 | 47.1 | 17.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19153477
|Title=Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study
|OA=1
}}

{{PMID Auto
|PMID=19891592
|Title=Association Among Polymorphisms at MYH9, Environmental Factors, and Nonsyndromic Orofacial Clefts in Western China
}}

{{PMID Auto
|PMID=21245129
|Title=Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese
}}

{{omim
|id=119530
|rsnum=3752462
}}

{{PMID Auto
|PMID=21968013
|Title=Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans
|OA=1
}}

{{PMID Auto
|PMID=18716610
|Title=Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate.
|OA=1
}}

{{PMID Auto
|PMID=18794854
|Title=MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=18794856
|Title=MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=19177153
|Title=Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=19764949
|Title=Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.
|OA=1
}}

{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|OA=1
}}

{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
|OA=1
}}

{{PMID Auto
|PMID=20634883
|Title=Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
|OA=1
}}

{{PMID Auto
|PMID=23470845
|Title=Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort
}}

{{PMID Auto
|PMID=22956460
|Title=Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}